Reuters logo
BRIEF-Reata Pharmaceuticals secures $35 mln term loan facility
April 3, 2017 / 11:13 AM / 6 months ago

BRIEF-Reata Pharmaceuticals secures $35 mln term loan facility

April 3 (Reuters) - Reata Pharmaceuticals Inc

* Reata Pharmaceuticals, Inc. secures $35 million term loan facility

* Reata Pharmaceuticals Inc says entered into a $35 million loan and security agreement with Oxford Finance Llc and Silicon Valley Bank

* Reata Pharma - proceeds will be utilized primarily to support multiple phase 2, 3 clinical trial programs for bardoxolone methyl and omavaloxolone Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below